AstraZeneca Says No to Pfizer's $119B Takeover Bid

The board of AstraZeneca rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that has led to a slide in the U.K. company's share price. In a statement Monday, AstraZeneca's board said it "reiterates its confidence in AstraZeneca's ability to deliver on its prospects as an independent, science led business." Read the full story

More News:

All news »

What are your comments?

Join the discussion today. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments